Project Details
Description
PERL: A multicenter clinical trial of allopurinol to prevent GFR loss in T1D
| Status | Finished |
|---|---|
| Effective start/end date | 9/30/13 → 6/30/20 |
Funding
- JOSLIN DIABETES CENTER, INC.
- NATIONAL INSTITUTES OF HEALTH (NIH)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.